Rice University logoDr. Rebecca Richards-Kortum
Top blue bar image
Optical Spectroscopy and Imaging Laboratory


Diagnostic test aimed at detecting virus in infants, viral loads in older patients in low-resource settings more »
Rice developing mobile DNA test for HIV>

We develop cost-effective optical imaging and spectroscopy tools to reduce the incidence and mortality of cancer and infectious disease through early detection at the point-of-care. In collaboration with the UT MD Anderson Cancer Center, we have developed novel cellular and molecular imaging technologies to recognize signatures of early neoplastic disease.  At the same time, we have developed optically active, targeted nanoparticles and fluorescent dyes to image directly the molecular hallmarks of cancer.  Through clinical trials at MD Anderson, Mount Sinai Medical Center, and Tata Memorial Hospital in Mumbai, India we have optimized these agents and imaging systems, demonstrating that they can detect precancerous lesions and early cancers in the oral cavity and the esophagus with high sensitivity and specificity.   More recently, we have initiated a multi-disciplinary effort to develop molecular specific contrast agents and optical micro-fluidic chips for point-of-care detection of infectious disease, through collaborations at Baylor College of Medicine and the University of Texas Medical Branch in Galveston.


September 9, 2016
Eric Yang wins Outstanding Teaching Assistant Award by the Department of Bioengineering

September 9, 2016
Third Annual Innovation Symposium winners

March 11, 2016
90 Second Thesis Competition Winners

February 22, 2016
Meaghan Bond's publication receives press coverage

More News »